Bryan Smith

3.7k total citations
40 papers, 1.2k citations indexed

About

Bryan Smith is a scholar working on Public Health, Environmental and Occupational Health, Pharmacology and Molecular Biology. According to data from OpenAlex, Bryan Smith has authored 40 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Public Health, Environmental and Occupational Health, 11 papers in Pharmacology and 6 papers in Molecular Biology. Recurrent topics in Bryan Smith's work include Malaria Research and Control (18 papers), Drug-Induced Hepatotoxicity and Protection (9 papers) and Mosquito-borne diseases and control (6 papers). Bryan Smith is often cited by papers focused on Malaria Research and Control (18 papers), Drug-Induced Hepatotoxicity and Protection (9 papers) and Mosquito-borne diseases and control (6 papers). Bryan Smith collaborates with scholars based in United States, United Kingdom and Thailand. Bryan Smith's co-authors include Youry Se, Delia Bethell, Paktiya Teja‐Isavadharm, Sabaithip Sriwichai, Mark M. Fukuda, Geoffrey S. Dow, Duong Socheat, Emma Jones, Kurt E. Schaecher and Harald Noedl and has published in prestigious journals such as Annals of Internal Medicine, PLoS ONE and Journal of Molecular Biology.

In The Last Decade

Bryan Smith

39 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bryan Smith United States	19	529	203	184	158	140	40	1.2k
Thomas Baranek France	25	243 0.5×	655 3.2×	1.2k 6.5×	219 1.4×	28 0.2×	42	2.2k
Afsheen Raza Qatar	16	125 0.2×	724 3.6×	241 1.3×	226 1.4×	48 0.3×	56	1.4k
Danielle N McLennan Australia	10	116 0.2×	237 1.2×	98 0.5×	80 0.5×	103 0.7×	11	656
Gurinder Singh India	19	320 0.6×	202 1.0×	69 0.4×	52 0.3×	457 3.3×	52	1.5k
P Wright United Kingdom	23	692 1.3×	292 1.4×	222 1.2×	114 0.7×	180 1.3×	56	2.0k
Shufeng Liu United States	22	201 0.4×	365 1.8×	189 1.0×	541 3.4×	105 0.8×	62	1.8k
Chris Bird United Kingdom	21	121 0.2×	406 2.0×	903 4.9×	119 0.8×	406 2.9×	88	1.9k
Mahboobeh Zarrabi Iran	19	169 0.3×	268 1.3×	94 0.5×	160 1.0×	10 0.1×	47	1.1k
George J. Hill United States	19	158 0.3×	272 1.3×	137 0.7×	44 0.3×	80 0.6×	78	1.3k
S. B. Hanauer United States	20	256 0.5×	233 1.1×	804 4.4×	152 1.0×	115 0.8×	46	3.2k

Countries citing papers authored by Bryan Smith

Since Specialization

Citations

This map shows the geographic impact of Bryan Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan Smith more than expected).

Fields of papers citing papers by Bryan Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryan Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan Smith. The network helps show where Bryan Smith may publish in the future.

Co-authorship network of co-authors of Bryan Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Bryan Smith. A scholar is included among the top collaborators of Bryan Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryan Smith. Bryan Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hoepner, Robert, Mathias Abegg, Christopher Linington, et al.. (2022). Antineonatal Fc Receptor Antibody Treatment Ameliorates MOG-IgG–Associated Experimental Autoimmune Encephalomyelitis. Neurology Neuroimmunology & Neuroinflammation. 9(2). 18 indexed citations

Smith, Bryan, et al.. (2022). A phase II, double blind, placebo-controlled, randomized evaluation of the safety and efficacy of tafenoquine in patients with mild-moderate COVID-19 disease. New Microbes and New Infections. 47. 100986–100986. 2 indexed citations

Lightwood, Daniel, Kaushik Sarkar, Alison Turner, et al.. (2018). Efficacy of an Inhaled IL-13 Antibody Fragment in a Model of Chronic Asthma. American Journal of Respiratory and Critical Care Medicine. 198(5). 610–619. 24 indexed citations

Smith, Bryan, Louis Christodoulou, Kevin Greenslade, et al.. (2018). Generation of two high affinity anti-mouse FcRn antibodies: Inhibition of IgG recycling in wild type mice and effect in a mouse model of immune thrombocytopenia. International Immunopharmacology. 66. 362–365. 16 indexed citations

Kießling, Peter, Rocío Lledó‐García, Shikiko Watanabe, et al.. (2017). The FcRn inhibitor rozanolixizumab reduces human serum IgG concentration: A randomized phase 1 study. Science Translational Medicine. 9(414). 152 indexed citations

Dow, Geoffrey S. & Bryan Smith. (2017). The blood schizonticidal activity of tafenoquine makes an essential contribution to its prophylactic efficacy in nonimmune subjects at the intended dose (200 mg). Malaria Journal. 16(1). 209–209. 13 indexed citations

Dow, Geoffrey S., et al.. (2017). Tafenoquine is not neurotoxic following supertherapeutic dosing in rats. Travel Medicine and Infectious Disease. 17. 28–34. 5 indexed citations

Dow, Geoffrey S., Jun Liu, Gina Lin, et al.. (2015). Summary of anti-malarial prophylactic efficacy of tafenoquine from three placebo-controlled studies of residents of malaria-endemic countries. Malaria Journal. 14(1). 473–473. 20 indexed citations

Li, Qigui, Shon Remich, Scott R. Miller, et al.. (2014). Pharmacokinetic evaluation of intravenous artesunate in adults with uncomplicated falciparum malaria in Kenya: a phase II study. Malaria Journal. 13(1). 281–281. 11 indexed citations

10.

Marcsisin, Sean R., Jason Sousa, Gregory A. Reichard, et al.. (2014). Tafenoquine and NPC-1161B require CYP 2D metabolism for anti-malarial activity: implications for the 8-aminoquinoline class of anti-malarial compounds. Malaria Journal. 13(1). 2–2. 67 indexed citations

11.

Dow, Geoffrey S., William F. McCarthy, Mark Reid, et al.. (2014). A retrospective analysis of the protective efficacy of tafenoquine and mefloquine as prophylactic anti-malarials in non-immune individuals during deployment to a malaria-endemic area. Malaria Journal. 13(1). 49–49. 30 indexed citations

12.

Fowler, Robyn, Driton Vllasaliu, Francisco Fernández‐Trillo, et al.. (2013). Nanoparticle Transport in Epithelial Cells: Pathway Switching Through Bioconjugation. Small. 9(19). 3282–3294. 53 indexed citations

13.

Fowler, Robyn, Driton Vllasaliu, Franco H. Falcone, et al.. (2013). Uptake and transport of B 12 -conjugated nanoparticles in airway epithelium. Journal of Controlled Release. 172(1). 374–381. 35 indexed citations

14.

Bethell, Delia, Youry Se, Chanthap Lon, et al.. (2011). Artesunate Dose Escalation for the Treatment of Uncomplicated Malaria in a Region of Reported Artemisinin Resistance: A Randomized Clinical Trial. PLoS ONE. 6(5). e19283–e19283. 52 indexed citations

15.

Deye, Gregory A., R. Scott Miller, Carola J. Salas, et al.. (2011). Prolonged Protection Provided by a Single Dose of Atovaquone-Proguanil for the Chemoprophylaxis of Plasmodium falciparum Malaria in a Human Challenge Model. Clinical Infectious Diseases. 54(2). 232–239. 27 indexed citations

16.

Lin, Jessica T., Delia Bethell, Stuart D. Tyner, et al.. (2011). Plasmodium falciparum Gametocyte Carriage Is Associated with Subsequent Plasmodium vivax Relapse after Treatment. PLoS ONE. 6(4). e18716–e18716. 18 indexed citations

17.

Smith, Bryan, Ladaporn Bodhidatta, Stephanie A Richard, et al.. (2010). Etiology of Diarrhea in Young Children and Patterns of Antibiotic Resistance in Cambodia. The Pediatric Infectious Disease Journal. 30(4). 331–335. 75 indexed citations

18.

Noedl, Harald, Youry Se, Sabaithip Sriwichai, et al.. (2010). Artemisinin Resistance in Cambodia: A Clinical Trial Designed to Address an Emerging Problem in Southeast Asia. Clinical Infectious Diseases. 51(11). e82–e89. 146 indexed citations

19.

Lü, Yanling, Stephen E. Harding, Alison Turner, et al.. (2007). Effect of PEGylation on the Solution Conformation of Antibody Fragments. Journal of Pharmaceutical Sciences. 97(6). 2062–2079. 48 indexed citations

20.

Croxtall, Jamie D., Hua‐Lin Wu, Hsi‐Yuan Yang, et al.. (1998). Lipocortin 1 co-associates with cytokeratins 8 and 18 in A549 cells via the N-terminal domain. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1401(1). 39–51. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact